Nasus Pharma Ltd. (NSRX)

Nasus Pharma will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$8.00 - $10.00

Shares Offered

1,250,000

Deal Size

$11.25M

Despegar.com Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	0.74	0.58
Research & Development	0.34	0.57
Operating Expenses	1.08	1.15
Operating Income	-1.08	-1.15
Interest Expense / Income	0.03	0.05
Other Expense / Income	0.43	-0.15
Pretax Income	-1.53	-1.05
Net Income	-1.53	-1.05
Free Cash Flow	-0.67	-1.03
EBITDA	-1.5	-1
EBIT	-1.5	-1

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).